Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Domanski

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|July 12, 2007
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDenise E Bonds, Ella Mae Kurashige, Richard Bergenstal, et al.
Journal of the American College of Cardiology|March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh, William E Boden, Vera Bittner, et al.
Circulation|November 21, 2007
Influence of albuminuria on cardiovascular risk in patients with stable coronary artery diseaseScott D Solomon, Julie Lin, Caren G Solomon, et al.
Journal of the American College of Cardiology|September 20, 2014
Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trialGeorge D Dangas, Michael E Farkouh, Lynn A Sleeper, et al.
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
American Heart Journal|February 22, 2003
Angiographic changes in saphenous vein grafts are predictors of clinical outcomesGenell L Knatterud, Carl White, Nancy L Geller, et al.
Journal of the American College of Cardiology|October 29, 2013
Lipoprotein(a) for risk assessment in patients with established coronary artery diseaseMichelle L O'Donoghue, David A Morrow, Sotirios Tsimikas, et al.
Journal of the American College of Cardiology|November 15, 2018
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On StudyMichael E Farkouh, Michael Domanski, George D Dangas, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
The New England Journal of Medicine|November 6, 2012
Strategies for multivessel revascularization in patients with diabetesMichael E Farkouh, Michael Domanski, Lynn A Sleeper, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|July 12, 2007
Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialDenise E Bonds, Ella Mae Kurashige, Richard Bergenstal, et al.
Journal of the American College of Cardiology|March 19, 2013
Risk factor control for coronary artery disease secondary prevention in large randomized trialsMichael E Farkouh, William E Boden, Vera Bittner, et al.
Circulation|November 21, 2007
Influence of albuminuria on cardiovascular risk in patients with stable coronary artery diseaseScott D Solomon, Julie Lin, Caren G Solomon, et al.
Journal of the American College of Cardiology|September 20, 2014
Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trialGeorge D Dangas, Michael E Farkouh, Lynn A Sleeper, et al.
American Heart Journal|October 17, 2012
The Future REvascularization Evaluation in patients with Diabetes mellitus: optimal management of Multivessel disease (FREEDOM) trial: clinical and angiographic profile at study entrySameer Bansilal, Michael E Farkouh, Whady Hueb, et al.
American Heart Journal|February 22, 2003
Angiographic changes in saphenous vein grafts are predictors of clinical outcomesGenell L Knatterud, Carl White, Nancy L Geller, et al.
Journal of the American College of Cardiology|October 29, 2013
Lipoprotein(a) for risk assessment in patients with established coronary artery diseaseMichelle L O'Donoghue, David A Morrow, Sotirios Tsimikas, et al.
Journal of the American College of Cardiology|November 15, 2018
Long-Term Survival Following Multivessel Revascularization in Patients With Diabetes: The FREEDOM Follow-On StudyMichael E Farkouh, Michael Domanski, George D Dangas, et al.
The New England Journal of Medicine|January 22, 2005
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureGust H Bardy, Kerry L Lee, Daniel B Mark, et al.
The New England Journal of Medicine|November 6, 2012
Strategies for multivessel revascularization in patients with diabetesMichael E Farkouh, Michael Domanski, Lynn A Sleeper, et al.
Pageof 5